Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 7Terminated 2Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lymphoma 13Multiple Myeloma 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 7Leukemia, Myeloid, Acute 7Leukemia 7Breast Neoplasms 7Neuroblastoma 6Neoplasms, Plasma Cell 6Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 6Lymphoma, Large-Cell, Immunoblastic 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Burkitt Lymphoma 5Leukemia, Lymphocytic, Chronic, B-Cell 4Hodgkin Disease 4Testicular Neoplasms 3Testicular Germ Cell Tumor 3Prostatic Neoplasms 3Myelodysplastic Syndromes 3Lymphoma, B-Cell, Marginal Zone 3Lung Neoplasms 3Leukemia, Myelomonocytic, Acute 3Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Central Nervous System Neoplasms 3Waldenstrom Macroglobulinemia 2Seminoma 2Ovarian Neoplasms 2

Interventions

Tretinoin 11Arsenic Trioxide 7Idarubicin 4Mitoxantrone 3Etoposide 3Daunorubicin 3Cytarabine 3Thioguanine 2Radiotherapy 2Cyclophosphamide 2sargramostim 1Watchful Waiting 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Mercaptopurine 1Hydroxyurea 1Filgrastim 1Busulfan 1Bortezomib 1Ascorbic Acid 1Amsacrine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Leukemia, Promyelocytic, Acute × Filgrastim × Clear all
NCT00002658 2013-12-19

Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 3 Unknown
2,000 enrolled
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neutropenia, Leukemia, Myeloid, Acute, Leukemia, Promyelocytic, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡